Related by context. All words. (Click for frequent words.) 65 PASI scores 63 achieving PASI 63 mg ustekinumab 61 HBeAg seroconversion 61 placebo dexamethasone 60 TMC# r 59 plus methotrexate 59 ACR# responses 58 receiving VICTRELIS 58 dose colchicine 58 baseline HbA1c 58 chlorambucil 58 achieved ACR# 58 serum urate 57 sUA levels 57 dose cytarabine 57 MCyR 57 CR nPR 57 EDSS scores 57 splenectomized patients 57 ZOMIG Nasal Spray 57 undetectable viral loads 57 8mg/kg 57 sustained virological response 57 tapentadol ER 57 oxycodone CR 57 HUMIRA achieved PASI 57 adefovir treated 56 antibody titers 56 virologic suppression 56 lumbar spine BMD 56 REYATAZ r arm 56 tipranavir r 56 dose Iluvien 56 hemoglobin A1c levels 56 FluCAM 56 virologic failure 56 ACR# response 56 paraprotein 56 Crohn Disease Activity 56 imipenem 56 Hb A1C 55 experienced virologic failure 55 mg BID 55 seroprotection 55 UPDRS scores 55 certolizumab 55 pegIFN 55 undetectable viral load 55 adalimumab 55 lamivudine refractory patients 55 neutrophil counts 55 platelet reactivity 55 Flu Cy 55 ALT elevation 55 PSA nadir 55 achieved sustained virological 55 dose dexamethasone 55 dose Ara 55 evaluable subjects 54 complete cytogenetic 54 mg/m2 dose 54 Platelet counts 54 cytogenetic response 54 seroconversion 54 virological failure 54 rizatriptan 54 dose interleukin 54 Available Seat Kilometres ASKs 54 IRLS score 54 CCyR 54 CDAI score 54 CR CRu 54 bortezomib refractory 54 LEXIVA r 54 serum testosterone 54 APTIVUS R 54 Virologic failure 54 HBV DNA 54 baseline A1C 53 mg kg dose 53 pegylated interferon alfa 53 serum HBV DNA 53 virologic response 53 sustained virologic response 53 infliximab therapy 53 oral allopurinol 53 atazanavir ritonavir 53 plus dexamethasone 53 EDSS score 53 follicular lymphomas 53 peginterferon 53 DAS# remission 53 HbA 1c levels 53 DAS# CRP 53 tipranavir ritonavir 53 HBeAg positive 53 -#.# log# 53 Aptivus ® 53 complete cytogenetic response 53 serum HCV RNA 53 struggling Pinkowski 53 patients evaluable 53 achieved sustained virologic 53 Profit Monthly Confidently 53 % mlink 53 nodular partial response 53 fluticasone salmeterol 53 & s2 = 53 serum creatinine levels 53 REMICADE monotherapy 53 biochemical relapse 53 FOLFOX4 53 pCR 53 bond yields UST#Y 52 doxorubicin cyclophosphamide 52 lopinavir 52 achieved CCyR 52 relapsed MM 52 sUA 52 annualized relapse 52 corticosteroid dose 52 CPAP adherence 52 hip BMD 52 decitabine 52 FTE staffing 52 plasma HCV RNA 52 DAS# scores 52 pegylated interferon ribavirin 52 timepoints 52 darunavir ritonavir 52 baseline FEV1 52 OC ZIPs 52 Lupuzor ™ 52 A1c levels 52 MADRS score 52 CsA 52 ACTEMRA TM 52 elevated LDH 52 ULORIC 52 microbiological eradication 52 OS = ISD/#/#/# 52 heavily pretreated patients 52 gemcitabine carboplatin 52 fructose diet 52 virologic 52 CuEQ equals Cu 52 LPV r 52 systolic blood pressures 52 complete remissions 52 undetectable HBV DNA 52 binary restenosis 52 Strongly Disapprove 52 serum phosphate levels 52 femoral neck BMD 52 CHOP chemotherapy 51 #mg BID [001] 51 mcg albinterferon alfa 2b 51 DLQI 51 glycated hemoglobin HbA1c 51 4mg/kg 51 SSRI SNRI 51 evaluable patients 51 heavily pretreated 51 intramuscular dose 51 NIHSS 51 Pegasys plus Copegus 51 tirofiban 51 remission CR 51 undergone splenectomy 51 FOLPI 51 lopinavir r 51 glycated hemoglobin levels 51 neoadjuvant radiation 51 hepatitis C genotype 51 Peg IFN 51 Tumors shrank 51 lamivudine 51 Fludara 51 receiving Vectibix monotherapy 51 preoperative chemotherapy 51 nilotinib 51 QTcF 51 hemoglobin concentrations 51 Ceplene/IL-2 51 dose cohorts 51 A1C levels 51 daunorubicin 51 HAI titers 51 5-FU/LV 51 CK # plasma concentrations 51 XIENCE V PROMUS Stent 51 antibody titer 51 definite stent thrombosis 51 ALT elevations 51 REYATAZ R 51 partial remissions 51 Ind Prod +#.# 51 methotrexate monotherapy 51 endoscopic remission 51 Pharmacokinetic parameters 51 MoxDuo TM IR 51 atorvastatin #mg 51 piperacillin tazobactam 51 log# copies mL 50 HbA1C levels 50 relapsers 50 #.#/#.# mmHg [001] 50 HAM D# scores 50 Score DAS# 50 interferon ribavirin 50 CRp 50 rapid virologic response 50 undetectable HCV RNA 50 MACCE 50 infliximab 50 infliximab monotherapy 50 entecavir 50 Kaplan Meier estimate 50 HbA 1c 50 HCV genotype 1 50 Spherion Employee Confidence Index 50 virological response 50 clodronate 50 Green Party Grune 50 MIAS#PUS 50 virological suppression 50 fullyear outturn represents 50 Topix subindexes 50 CIMZIA ™ 50 #.#ng/ml 50 lamivudine monotherapy 50 BENICAR 50 baseline LDH 50 peginterferon alfa 2a 50 virologic response EVR 50 STELARA 50 TSX subindexes 50 dose melphalan 50 asymptomatic carotid stenosis 50 APEAL scores 50 Index CDAI 50 TPV r 50 serum cortisol 50 seroprotective 50 azacitidine 50 Retail postpaid churn 50 neuropathy sensory 50 HbA1c levels 50 KRAS mutations occur 50 median CD4 50 mutated KRAS 50 CIMZIA TM 50 PASI score 50 peginterferon alfa 2b 50 Viral load 50 gemcitabine cisplatin 49 titers 49 mg Lucentis 49 REO saturation rates 49 achieve sustained virologic 49 Balance Luzon 49 HSNSI 49 interquartile range 49 PegIFN RBV 49 Partial Responses 49 HBeAg + 49 HbA1C 49 plus MTX 49 LEXIVA 49 PCA3 scores 49 Operative mortality 49 titer 49 alcohol refreshers 49 angiographic restenosis 49 tipranavir 49 oblimersen 49 receiving highly emetogenic 49 #mg QD [002] 49 pegylated alpha interferon 49 seropositive patients 49 intraocular inflammation 49 Consensus +#.# 49 abacavir lamivudine 49 SVR# 49 IELEC.T 49 % CI #.#-#.# [005] 49 fatigue asthenia 49 antiangiogenic therapy 49 ribavirin therapy 49 adefovir 49 aged ≥ 49 Off Magazines 49 PegIntron 49 TRXFLDPIPU 49 methotrexate MTX 49 nonresponders 49 TRXFLDAXPU 49 Hb levels 49 Munghana Lonene Listenership 49 serum CRP 49 HIV uninfected 49 Ishak fibrosis score 49 mg BID dose 49 EBMT criteria 49 irbesartan 49 CD4 + cell 49 DAS# [002] 49 posttreatment 49 rituximab refractory 49 relapsed SCLC 49 CNX midcap index 48 SX3P 48 iodixanol 48 VICTRELIS 48 hydroxyvitamin D levels 48 low dose dexamethasone 48 % Confidence Interval 48 Implied vols 48 NSTE ACS 48 Irrigated fields 48 log# reduction 48 MACUGEN 48 postintervention 48 implied volatilities tend 48 Electro Rent NASDAQ ELRC 48 bendamustine 48 IFN alfa 48 ritonavir boosted 48 baseline serum creatinine 48 fluvastatin 48 PDP MLR 48 degarelix 48 p = NS 48 tumor regressions 48 plus ribavirin 48 CNX Mid Cap 48 LS BMD 48 Upscale Nordstrom Inc. 48 mcg dose 48 % CI #.#-#.# [008] 48 YMRS 48 bonds US#YT RR 48 Capella doctoral 48 pegylated interferon 48 glyburide 48 VELCADE melphalan 48 from#.# [001] 48 PSADT 48 peginterferon alfa 2a #KD 48 HIV RNA 48 Relative humidity 48 null responders 48 viral suppression 48 thyroglobulin 48 fasting insulin 48 platelet counts 48 anti TNFs 48 gefitinib 48 mg qd 48 surveyed PCPs 48 fasting triglyceride levels 48 9bps 48 dose cohort 48 risk Hevezi 48 stomatitis pharyngitis 48 standard chemotherapy regimens 48 markup Tollin 48 evaluable 48 concentration Cmax 48 AZT zidovudine Retrovir 48 A1Cs 48 #μg [001] 48 workweek lengthened 48 HDRS 48 plus COPEGUS 48 diameter stenosis 48 pulmonary capillary wedge 48 DLTs 48 imatinib therapy 48 plus aztreonam 48 BSE# 48 edema peripheral 48 TEPA BLOCK 48 RECIST criteria 48 q8h 48 COMBIVIR 48 CDAI 47 GDAXI indexes 47 ximelagatran 47 glomerular filtration 47 Zevalin consolidation 47 HEX portfolio 47 ISECU.T 47 hemoglobin A1c HbA1c 47 Nominal incomes 47 cEVR 47 plasma creatinine 47 diastolic blood pressures 47 GSPF slid 47 pomalidomide 47 mcg kg 47 % CI #.#-#.# [003] 47 ITEQP.T Quote Profile Research 47 serum ALT 47 BPH Symptom Score 47 bezafibrate 47 clickthrough rates 47 biochemical recurrence 47 lymphocytosis 47 Assessed valuation AV 47 HbA 1C 47 log# 47 % CI #.#-#.# [007] 47 AXFJ 47 Partial Response 47 Inventories subtracted 47 plasma cortisol 47 enalapril 47 acetaminophen codeine 47 Kaplan Meier estimates 47 FOLFIRI 47 SUVmax 47 X ULN 47 albumin excretion 47 Standard msg 47 SCr 47 adalimumab Humira 47 CCR5 tropic HIV 47 IBNKS.T 47 estrogen receptor progesterone receptor 47 baseline CD4 + 47 circulating EPCs 47 TURBT 47 NABE forecasters predicted 47 yields DE#YT = TWEB 47 CSDs Dr Pepper 47 hormone deprivation 47 stage IIIB 47 CD4 lymphocyte count 47 hemagglutination inhibition 47 viral loads 47 Summary Box Mortgage 47 lifetime abstainers 47 PaO 2 47 preoperative PSA 47 #mmHg [002] 47 triglyceride concentration 47 follicular NHL 47 serum folate 47 Refinery utilization rebounded 47 SX6P 47 MBCPO 47 Plavix cautioning 47 Triglyceride levels 47 #mg BID [002] 47 IELT 47 Molex NASDAQ MOLXA 47 NNRTI resistance 47 TT genotype 47 THD + N 47 urinary calcium excretion 47 decibel dB 47 boosted atazanavir 47 urine albumin 47 FOLFOX6 47 FTSC closes 47 Cmax 47 refractory NSCLC 47 Hycamtin ® 47 BGTR# 47 Baseline characteristics 47 febuxostat 47 Merckx Hinault Miguel Indurain 47 Euro Libor #.# 47 carboplatin paclitaxel 47 vinorelbine 47 copies mL 47 asset allocators overweight 47 tumor shrinkage 47 Complication rates 47 poor metabolizers 47 TDF FTC 47 gadolinium enhancing lesions 47 plasma uric acid 47 confidence intervals CIs 47 #-#/# yielding #.# [001] 47 pegfilgrastim 47 very badly Berlinschi 47 median survivals 47 unfractionated heparin 47 galiximab 47 telaprevir dosed 47 #.#-#.# [005] 46 metastatic renal cell carcinoma 46 adalimumab etanercept 46 Surfactant gross 46 multivariate analyzes 46 apolipoprotein B 46 liver histology 46 glargine 46 Economically disadvantaged students 46 detectable HCV RNA 46 pegylated interferon alfa 2a 46 comparator PI r 46 log# IU mL 46 confidence interval #.#-#.# 46 nondepressed 46 genotype 1b 46 Endologix NASDAQ ELGX 46 prior chemotherapy regimens 46 IELEC.T Quote Profile Research 46 mg m² 46 cabazitaxel 46 μg mL 46 MELD scores 46 oral diclofenac 46 mitoxantrone 46 viral kinetics 46 μmol L 46 TUESDAY Mostly sunny 46 #mg/m# [002] 46 achieve sustained virological 46 Strongly Approve 46 myeloid blast 46 MIWD#PUS rose 46 prior relapsers 46 fludarabine 46 CTD Jeopardy 46 HOMA IR 46 unwanted proselytizing 46 normal ULN 46 DOXIL ® 46 Yedioth poll 46 nmol L. 46 imatinib 46 lenalidomide 46 surveyed rheumatologists 46 n Cooling Degree 46 genotypic resistance 46 Wartime PTSD 46 sorafenib Nexavar ® 46 target lesion revascularizations 46 raltegravir 46 ADHD RS 46 creatinine levels 46 microg 46 viral load 46 Merit FOM 46 seropositivity 46 emissions combustor 46 AUA BPH Symptom Score 46 Elitek 46 AST ALT 46 Subgroup analyzes 46 TAXUS Stent 46 activated Akt pAkt 46 IXIC slid 46 neutrophil count 46 ribavirin RBV 46 metformin IR 46 broader HDAX Index 46 dysesthesia 46 Broader stock 46 Towerbrook Partners 46 Hang seng 46 copies ml 46 FRMs 46 Pegasys ® 46 crazysharksman Castle Braai recommendations 46 IBDQ 46 μg liter 46 telbivudine 46 neoadjuvant chemotherapy 46 CVD mortality 46 mRCC 46 ARB telmisartan 46 ITEQP.T 46 IXIC climbed 46 naive HCV 46 Industrial Average futures 46 additive jitter 46 naïve HCV 46 NNRTI 46 RGT arm 46 IPSS 46 treat NNT 46 serum PSA 46 SBI TOP benchmark 46 atazanavir 46 unfavorable cytogenetics 46 allogeneic SCT 46 alfa 2a 46 piotr.skolimowski @ thomsonreuters.com 46 Response Evaluation Criteria 46 tegaserod 46 nonadherent 46 Jevtana 46 interferon alfa 2a 46 relapsed refractory multiple myeloma 46 RLS sufferers 46 Approaching Basic 46 prospectively stratified 46 Severe acneform rash 46 mg subcutaneous 46 ABC/3TC 46 insulin glargine 45 MMSE score 45 plasma concentrations 45 plusers 45 Ebidta margins 45 fluoxetine paroxetine 45 sunitinib sorafenib 45 cTnT levels 45 DJ Stoxx Telecoms 45 2 #/#-year CDs 45 lactate dehydrogenase LDH 45 nanomolar potency 45 rituximab 45 NIH CPSI 45 Kaplan Meier analysis 45 somatostatin analog 45 IXIC gained 45 Commended Performance 45 clickthrough rate 45 Corn silked 45 subcutaneously administered 45 RECIST 45 IFN α 45 Korea Kospi Index 45 ± SEM 45 interferon beta therapy 45 KS# KOSPI 45 DMARD 45 FOLFOX 45 serum triglyceride levels 45 sirolimus eluting stent 45 Medicare Advantage MLR 45 q#d 45 depressive symptom 45 inhospital mortality 45 serum concentrations 45 5FU 45 boosted protease inhibitor 45 HCV genotype 45 Taxotere ® 45 MabCampath 45 diastolic pressures 45 GSPINSC 45 LMWH 45 tenecteplase 45 periprocedural 45 ICD therapy 45 tinzaparin 45 Metal Ores-Gold/Silver group 45 metastatic RCC 45 Dermatologic Toxicity Dermatologic toxicities 45 DMARDs 45 dutiable imports 45 progression TTP 45 octreotide 45 #-# mg dL 45 mcg kg min 45 2bps 45 REYATAZ r 45 Himax Technologies NASDAQ HIMX 45 statewide unadjusted jobless 45 isoflavone intake 45 SPX sagged 45 value LTV ratios 45 Median PFS 45 IFL chemotherapy regimen 45 eplerenone 45 peg interferon 45 median PFS 45 de novo AML 45 SXNP 45 HSNSI stood 45 touchscreens Surface 45 imiquimod 45 By DENNIS DARROW 45 MXX gained 45 XELOX 45 Urinary infections 45 MMSE scores 45 rescheduled elective surgeries 45 Procoralan 45 dosing cohorts 45 mg/m2 cohort 45 nmol liter 45 TNF inhibitors 45 Vaxjo pronounced shur 45 pmol L 45 #/#mmHg 45 wateriest 45 homocysteine concentrations 45 Atacand 45 YERVOY 45 tolterodine 45 MSCIAPJ 45 BKLA 45 upper eyelids forehead 45 mg/m2/day 45 HbA1c 45 rhEPO 45 TMC# [001] 45 adriamycin 45 Stonemor Partners NASDAQ STON 45 TAXUS stent 45 IU ml 45 TOPX Quote Profile Research 45 GSPPM 45 vertebral fracture 45 cytotoxic chemotherapy 45 EGFR mutation positive 45 HBsAg 45 Very Unfavorable 45 KRAS wild 45 Solid Tumors RECIST 45 NRTI 45 systemic bioavailability 45 Debmar Mercury Family Feud 45 benchmark Ibovespa stock 45 estim ated fewer 45 tablets #:#:# 45 PANHANDLE Temperatures 45 subclinical hyperthyroidism 45 odanacatib 45 cGy 45 Nasdaq Composite NASDAQ COMP 45 calculated creatinine clearance 45 intensity pulsed ultrasound 45 SXMP 45 habitual snorers 45 Tumor regression 45 severe neutropenia 45 MIC# [001] 45 symptomatic intracerebral hemorrhage 45 HCV infected 45 Volume Terminals MIDS 45 FTMC FTSE 45 -#.# ± [002] 45 subthreshold depression 45 leukocyte count 45 GSPTSE unofficially closed 45 unresectable 44 FTSC FTSE 44 Complete Response CR 44 Hazard Ratio 44 TRXFLDGLPU 44 Blended ARPU 44 GOVERNMENT MEETINGS 44 FIRMAGON 44 mmol l 44 VFEND 44 Cariprazine 44 baseline FEV 44 US#YT RR 44 baseline CD4 44 broader BG# 44 Copegus ribavirin 44 bps yoy 44 note yields UST2YR 44 TOPX gained 44 mL/min/#.# m2 44 mU L 44 n = 44 metastatic malignant melanoma 44 mmol liter 44 vandetanib 44 del 5q myelodysplastic syndromes 44 BSE consumer durables 44 docetaxel chemotherapy 44 DAPT 44 adverse cytogenetics 44 NovoSeven ® 44 pegylated interferons 44 oncologic outcomes 44 BCG vaccinated 44 serum vitamin D 44 hemoglobin Hb 44 GCSEs graded 44 Elizabeth Arden NASDAQ RDEN 44 Calcineurin inhibitors 44 IVTA 44 7bps 44 EBITDAR margin 44 Absolute Breadth Index 44 q#h 44 #bps yoy [001] 44 enoxaparin 44 mm Stent 44 #.#-#.# GPA 44 #.#mmol L [002] 44 plasma concentration Cmax 44 Discounting civil servants 44 thyrotropin levels 44 Instanex FII index 44 mean ± SEM 44 sleeve lobectomy 44 Free Survival PFS 44 generation Z'ers 44 TOPIX shed 44 Total Harmonic Distortion 44 bortezomib 44 adjuvant systemic 44 Targretin capsules 44 HER2 expression 44 pollees 44 0.l 44 MILA#PUS 44 ECD kidneys 44 Peginterferon Alfa 2a 44 K ras mutations 44 g trans fats 44 radiographic progression 44 MIAPJMT#PUS 44 Upscale Nordstrom 44 Dropout rates 44 CLL SLL 44 Strongly Disapprove giving 44 Likert 44 grade cervical lesions 44 zoledronic acid 44 dasatinib 44 Erlotinib 44 undetectable PSA 44 bortezomib Velcade R 44 nitazoxanide 44 modified RECIST criteria 44 free survival PFS 44 6MWD 44 EBDITA 44 proton MR spectroscopy 44 elevated LDL 44 plus prednisone 44 cells mcL 44 chemotherapy docetaxel 44 anti TNF 44 locoregional recurrence 44 lumiliximab 44 rituximab monotherapy 44 carb dieters 44 sorafenib 44 differently Widmer Schlump 44 % CI #.#-#.# [006] 44 IU mL 44 SOXX gained 44 Nasdaq composite COMP 44 follicular lymphoma 44 peg IFN 44 mTSS 44 #bps qoq [001] 44 ACR# [002] 44 tPSA 44 Leverage ratios 44 attain statistical significance 44 Very Satisfied 44 abiraterone acetate 44 placebo 44 estimated glomerular filtration 44 darbepoetin alfa 44 CAELYX 44 waist circumference measurements 44 topotecan 44 jana.mlcochova @ thomson.com 44 tumor histology 44 clot busting therapy 44 BKEUR 44 benign nodules 44 XLI SPY 44 placebo p 44 Topotecan 44 continuously abstinent 44 dacarbazine 44 taxane therapy 44 ASPS comprises 44 Indonesia JSX Composite 44 CI #.#-#.# [001] 44 retry Evridge pass 44 Molson Coors 3Q 44 serum calcium 44 prior antiangiogenic therapy 44 indapamide 44 lifts Mount Sunapee 44 Stent thrombosis 44 SXKP 44 RECIST Response Evaluation Criteria 44 Omiganan 44 Morgan Stanley Cyclical 44 Academically Acceptable rating 44 nadir CD4 cell 44 NYSE XOI 44 Intermediate maturities 44 recurrent GBM 44 Paris Cac 44 non squamous histology 44 erlotinib 44 rFSH 44 result Panasonic Toughbooks 44 W/cm2 44 metastatic lesions 44 μV 44 CHD mortality 44 p = #.# [003] 44 mCRPC 44 microvolts 44 bicalutamide 44 violent victimizations 44 grade fever chills 44 outturn represents 44 nonfasting triglyceride levels 44 trastuzumab 44 heavy rains Jaua 44 biopsy Gleason 44 V bustline 44 excluding reimbursables 43 6bps 43 interferon therapy 43 double digit growths 43 azacytidine 43 drywall Brincku 43 Comparable coffeehouse 43 ispinesib administered 43 hybrid adjustables 43 CHD CVD 43 tertile 43 #-#/# yielding [002] 43 Martha Kanter undersecretary 43 BTM UBS 43 richest quintile 43 Molecular Weight Heparin 43 Sawlog prices 43 molecular weight heparins 43 HLA DR2 43 cystoscopic 43 Fludarabine 43 HBsAg positive 43 belimumab 43 Nonfatal shootings 43 metastatic CRC 43 Solid Tumors criteria 43 nonteaching hospitals 43 HealthStream Learning 43 Comparable RevPAR 43 total harmonic distortion 43 HCV RNA 43 CPI NYSE CPY 43 indicating transmitters transducers 43 NHANES III 43 glycemic index foods 43 Taiwan Taiex weighted 43 clinically meaningful improvements 43 Stretching Techniques 43 Burst Mode operation 43 acetazolamide 43 olmesartan 43 Personal Consumption Expenditures PCE 43 Shingles vaccine 43 Loss severities 43 Poland WIG# 43 XLV SPY Relative Strength 43 FredHager.com Newsletter 43 Soybeans grains 43 Regents diplomas 43 allopurinol 43 hertz Hz 43 CRu 43 -basil chiffonade 43 prescribed CRESTOR 43 Occupancy Rate 43 Untreated mice 43 LKQ NASDAQ LKQX 43 EGFR TKI 43 HSI +#.# 43 BMI z 43 coinfected patients 43 benchmark Ibovespa 43 HBeAg positive chronic hepatitis 43 intravenous IV iron 43 selembu 43 Nifty PCR 43 Target Vessel Revascularization 43 SofTech solutions 43 + Hanzo 43 NIHSS score 43 NMIBC 43 #mg QD [001] 43 Target Lesion Revascularization TLR 43 chronic HCV genotype 43 Nonfood inflation 43 temsirolimus 43 Advancers trounced decliners 43 untreated mice 43 dutasteride 43 UKXUKX 43 interrater reliability 43 coinfected 43 durable remissions